Dr Richard T O'brien, MD in Holladay, UT - Pediatrics

Dr Richard T O'brien, MD is a Pediatrics physician based in Holladay, Utah. Dr Richard T O'brien is licensed to practice in Utah (license number 161126-8905) and his current practice location is 4527 South 2995 East, Holladay, Utah. He can be reached at his office (for appointments etc.) via phone at (801) 272-8060.

NPI number for Dr Richard T O'brien is 1275850752 and his current mailing address is 4527 South 2995 East, Holladay, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1275850752.

Contact Information

	Dr Richard T O'brien, MD
	4527 South 2995 East, Holladay, UT 84117-4636
	(801) 272-8060
	Not Available

Physician's Profile

Full Name	Dr Richard T O'brien
Gender	Male
Speciality	Pediatrics
Location	4527 South 2995 East, Holladay, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1275850752
Provider Enumeration Date: 04/23/2010
Last Update Date: 04/23/2010

Medical Identifiers

Medical identifiers for Dr Richard T O'brien such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275850752	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	161126-8905 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Richard T O'brien is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Richard T O'brien, MD 4527 South 2995 East, Holladay, UT 84117-4636 Ph: (801) 272-8060	Dr Richard T O'brien, MD 4527 South 2995 East, Holladay, UT 84117-4636 Ph: (801) 272-8060

News Archive

Tengion presents Neo-Kidney Augment development program at ISCT Symposium

Tengion, Inc. presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco. The presentation highlighted new results from Tengion's Neo-Kidney Augment development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension.

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.

$4.8 million grant from CDC to establish Indiana Center of Excellence in Public Health Informatics

Researchers from Indiana University and the Regenstrief Institute, with its world-renowned medical informatics research group and regional health information exchange, have been awarded a $4.8 million grant by the Centers for Disease Control and Prevention to create the Indiana Center of Excellence in Public Health Informatics, one of only four such centers in the nation.

Increased mortality rates in Bangladesh is associated with arsenic exposure, study finds

Between 33 and 77 million people in Bangladesh have been exposed to arsenic in the drinking water-a catastrophe that the World Health Organization has called "the largest mass poisoning in history." A new study published in the current issue of the medical journal The Lancet provides the most complete and detailed picture to date of the high mortality rates associated with this exposure, which began with the widespread installation of tube wells throughout the country 30 years ago-a measure intended to control water-bourne diseases.

Dr Richard T O'brien, MD - Pediatrics in Holladay, UT